Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Rozacor 20 mg vs Crestor 20 mg under fasting conditions
TCTR20210521001Phase 1Not yet recruiting
- Sponsor
- Government Pharmaceutical Organization
- Start
- Oct 2021
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in hypercholesterolemia, combined dyslipidaemia, hyperlipidemia and 1 more (2 arms), sponsored by Government Pharmaceutical Organization. Planned start Oct 2021; status: not yet recruiting.
02
Conditions
hypercholesterolemiacombined dyslipidaemiahyperlipidemiacardiac morbidity
Beyond the preview
Go deeper on TCTR20210521001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210521001.